TY - JOUR
T1 - Transient naive reprogramming corrects hiPS cells functionally and epigenetically
AU - Buckberry, Sam
AU - Liu, Xiaodong
AU - Poppe, Daniel
AU - Tan, Jia Ping
AU - Sun, Guizhi
AU - Chen, Joseph
AU - Nguyen, Trung Viet
AU - de Mendoza Soler, Alex
AU - Pflueger, Jahnvi
AU - Frazer, Thomas
AU - Vargas Landin, Dulce
AU - Paynter, Jacob M
AU - Smits, Nathan
AU - Liu, Ning
AU - Ouyang, John F
AU - Rossello, Fernando J
AU - Chy, Hun S.
AU - Rackham, Owen J L
AU - Laslett, Andrew L.
AU - Breen, James
AU - Faulkner, Geoffrey J.
AU - Nefzger, Christian M
AU - Polo, Jose M
AU - Lister, Ryan
N1 - This work was supported by the following sources. R.L.: National Health and Medical Research Council (NHMRC) project grant 1069830, NHMRC investigator grant 1178460, Silvia and Charles Viertel Senior Medical Research Fellowship, Howard Hughes Medical Institute International Research Scholarship, Western Australia Department of Health Research Excellence Award and Australian Research Council (ARC) LE170100225. J. M. Polo: Silvia and Charles Viertel Senior Medical Research Fellowship, ARC Future Fellowship FT180100674, and NHMRC project grants 1069830 and 1104560. S.B.: NHMRC/ARC Dementia Research Development Fellowship 1111206 and Western Australia Department of Health Merit Award 1174766. X.L,: Monash International Postgraduate Research Scholarship, Monash Graduate Scholarship and the Carmela and Carmelo Ridolfo Prize in Stem Cell Research, Westlake Education Foundation. A.L.L.: NHMRC project grant 1104560. C.M.N.: Monash University strategic grant. O.J.L.R. and J.F.O.: Singapore National Research Foundation Competitive Research Programme NRF-CRP20-2017-0002. G.J.F.: NHMRC investigator grant 1173711 and the Mater Foundation. T.V.N. and D.B.V.-L.: Forrest Research Foundation PhD scholarships. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The South Australian immunoGENomics Cancer Institute (SAiGENCI) received grant funding from the Australian Government. Genomics data was generated at the ACRF Centre for Advanced Cancer Genomics and Genomics WA. We thank staff at Monash Flowcore Facility and UWA Centre for Microscopy, Characterisation and Analysis for providing high-quality cell sorting services and technical input; S. Wang and T. Wilson for assistance with library preparation and Illumina sequencing; G. Neely and O. Bogdanovic for valuable feedback on this work; and T. Heng for providing MSC cell lines.
PY - 2023/8/24
Y1 - 2023/8/24
N2 - Cells undergo a major epigenome reconfiguration when reprogrammed to human induced pluripotent stem cells (hiPS cells). However, the epigenomes of hiPS cells and human embryonic stem (hES) cells differ significantly, which affects hiPS cell function1–8. These differences include epigenetic memory and aberrations that emerge during reprogramming, for which the mechanisms remain unknown. Here we characterized the persistence and emergence of these epigenetic differences by performing genome-wide DNA methylation profiling throughout primed and naive reprogramming of human somatic cells to hiPS cells. We found that reprogramming-induced epigenetic aberrations emerge midway through primed reprogramming, whereas DNA demethylation begins early in naive reprogramming. Using this knowledge, we developed a transient-naive-treatment (TNT) reprogramming strategy that emulates the embryonic epigenetic reset. We show that the epigenetic memory in hiPS cells is concentrated in cell of origin-dependent repressive chromatin marked by H3K9me3, lamin-B1 and aberrant CpH methylation. TNT reprogramming reconfigures these domains to a hES cell-like state and does not disrupt genomic imprinting. Using an isogenic system, we demonstrate that TNT reprogramming can correct the transposable element overexpression and differential gene expression seen in conventional hiPS cells, and that TNT-reprogrammed hiPS and hES cells show similar differentiation efficiencies. Moreover, TNT reprogramming enhances the differentiation of hiPS cells derived from multiple cell types. Thus, TNT reprogramming corrects epigenetic memory and aberrations, producing hiPS cells that are molecularly and functionally more similar to hES cells than conventional hiPS cells. We foresee TNT reprogramming becoming a new standard for biomedical and therapeutic applications and providing a novel system for studying epigenetic memory.
AB - Cells undergo a major epigenome reconfiguration when reprogrammed to human induced pluripotent stem cells (hiPS cells). However, the epigenomes of hiPS cells and human embryonic stem (hES) cells differ significantly, which affects hiPS cell function1–8. These differences include epigenetic memory and aberrations that emerge during reprogramming, for which the mechanisms remain unknown. Here we characterized the persistence and emergence of these epigenetic differences by performing genome-wide DNA methylation profiling throughout primed and naive reprogramming of human somatic cells to hiPS cells. We found that reprogramming-induced epigenetic aberrations emerge midway through primed reprogramming, whereas DNA demethylation begins early in naive reprogramming. Using this knowledge, we developed a transient-naive-treatment (TNT) reprogramming strategy that emulates the embryonic epigenetic reset. We show that the epigenetic memory in hiPS cells is concentrated in cell of origin-dependent repressive chromatin marked by H3K9me3, lamin-B1 and aberrant CpH methylation. TNT reprogramming reconfigures these domains to a hES cell-like state and does not disrupt genomic imprinting. Using an isogenic system, we demonstrate that TNT reprogramming can correct the transposable element overexpression and differential gene expression seen in conventional hiPS cells, and that TNT-reprogrammed hiPS and hES cells show similar differentiation efficiencies. Moreover, TNT reprogramming enhances the differentiation of hiPS cells derived from multiple cell types. Thus, TNT reprogramming corrects epigenetic memory and aberrations, producing hiPS cells that are molecularly and functionally more similar to hES cells than conventional hiPS cells. We foresee TNT reprogramming becoming a new standard for biomedical and therapeutic applications and providing a novel system for studying epigenetic memory.
UR - http://www.scopus.com/inward/record.url?scp=85168110418&partnerID=8YFLogxK
U2 - 10.1038/s41586-023-06424-7
DO - 10.1038/s41586-023-06424-7
M3 - Article
C2 - 37587336
SN - 1476-4687
VL - 620
SP - 863
EP - 872
JO - Nature
JF - Nature
IS - 7975
ER -